{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-057648","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2023-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.941540+00:00","generated_at":"2026-06-07T13:11:57.740538+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eterna Therapeutics issues $1.5M promissory note to Charles Cherington due Jan 8, 2024 at 6%","bullets":["Principal amount $1,500,000; interest rate 6% per annum; matures January 8, 2024.","Promissory Note is a senior unsecured obligation; ranks equally with existing unsubordinated debt.","Proceeds received on December 8, 2023; use of proceeds not specified beyond general corporate purposes.","Customary events of default include payment failure, bankruptcy, material adverse effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-057648","json":"https://secwatch.observer/filing/0001140361-23-057648.json","markdown":"https://secwatch.observer/filing/0001140361-23-057648.md","text":"https://secwatch.observer/filing/0001140361-23-057648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036123057648/0001140361-23-057648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036123057648/ef20016590_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:11:57.740538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d136c317ed6cba510231cd6088310be32ae995d1","claim":"Ernexa Therapeutics Inc. incurred loan of $1,500,000 with Charles Cherington at 6.0% per annum maturing January 8, 2024.","evidence_excerpt":"On December 8, 2023, Eterna Therapeutics Inc. (the “Company”) issued a 6.0% promissory note with an aggregate principal amount of $1,500,000 (the “Promissory Note”) to Charles Cherington.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/748592/000114036123057648/0001140361-23-057648-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$1,500,000"},{"label":"Counterparty","value":"Charles Cherington"},{"label":"Rate","value":"6.0% per annum"},{"label":"Maturity","value":"January 8, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}